Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing

Details for Australian Patent Application No. 2005240078 (hide)

Owner Allergan, Inc.

Inventors Chang-Lin, Joan-En; Olejnik, Orest; Shiah, Jane Guo; Huang, Glenn T.; Sarrazin, Christian; Boix, Michele; Nivaggioli, Thierry; Hughes, Patrick M.

Agent Davies Collison Cave

Pub. Number AU-A-2005240078

PCT Pub. Number WO2005/107707

Priority 60/629,928 22.11.04 US; 60/567,339 30.04.04 US; 11/119,024 29.04.05 US

Filing date 29 April 2005

Wipo publication date 17 November 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/07 (2006.01)

A61K 31/203 (2006.01)

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107707 Priority application(s): WO2005/107707

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240081-Anti-excitotoxic sustained release intraocular implants and related methods

2005240073-Apparatus and method for ocular treatment